Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67.
Zhao F, Zhao J, Wei X, Shi Y, Xu N, Zhu S, Chen J, Sun G, Dai J, Wang Z, Zhang X, Liang J, Hu X, Liu H, Zhao J, Liu Z, Nie L, Shen P, Chen N, Zeng H.
Zhao F, et al. Among authors: zeng h.
Prostate. 2024 Jul;84(10):932-944. doi: 10.1002/pros.24710. Epub 2024 Apr 17.
Prostate. 2024.
PMID: 38629249